Startseite>>Signaling Pathways>> PROTAC>>m-PEG5-succinimidyl carbonate

m-PEG5-succinimidyl carbonate

Katalog-Nr.GC67138

m-PEG5-Succinimidylcarbonat ist ein nicht spaltbarer PEG-ADC-Linker mit 5 Einheiten, der bei der Synthese von Antikörper-Wirkstoff-Konjugaten (ADCs) verwendet wird. m-PEG5-Succinimidylcarbonat ist ein PEG/Alkyl/Ether-basierter PROTAC-Linker, der bei der Synthese von PROTACs verwendet werden kann.

Products are for research use only. Not for human use. We do not sell to patients.

m-PEG5-succinimidyl carbonate Chemische Struktur

Cas No.: 1058691-00-1

Größe Preis Lagerbestand
1g Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

m-PEG5-succinimidyl carbonate is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG5-succinimidyl carbonate is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs.

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].

[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.

Bewertungen

Review for m-PEG5-succinimidyl carbonate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for m-PEG5-succinimidyl carbonate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.